Atossa Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
10 Apr 24 | Buy€41,179 | Jonathan Finn | Individual | 25,000 | €1.65 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 22,254 | 0.0177% |
Individual Insiders | 51,158 | 0.0407% |
VC/PE Firms | 7,762,500 | 6.17% |
Institutions | 27,097,262 | 21.5% |
General Public | 90,824,242 | 72.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,667,615 | €12.7m | 5.12% | no data | |||
7,762,500 | €10.2m | 0% | 4.75% | |||
6,485,877 | €8.5m | 12.7% | no data | |||
2,769,684 | €3.6m | 128% | no data | |||
1,663,041 | €2.2m | 237% | no data | |||
1,550,910 | €2.0m | 11.9% | no data | |||
431,861 | €568.1k | -43.6% | no data | |||
411,667 | €541.5k | 3,160% | no data | |||
369,988 | €486.7k | 0% | no data | |||
267,208 | €351.5k | 18.4% | no data | |||
260,081 | €342.1k | 566% | no data | |||
250,398 | €329.4k | 0% | 0.03% | |||
209,241 | €275.2k | 36.7% | no data | |||
201,498 | €265.1k | 59.9% | no data | |||
182,786 | €240.5k | 450% | no data | |||
170,733 | €224.6k | 0% | no data | |||
157,426 | €207.1k | -36.7% | no data | |||
135,118 | €177.7k | 0% | no data | |||
105,910 | €139.3k | 0% | no data | |||
103,872 | €136.6k | 35.6% | no data | |||
102,665 | €135.1k | -83.7% | no data | |||
87,800 | €115.5k | 0% | no data | |||
75,126 | €98.8k | -10.5% | 0.01% | |||
69,402 | €91.3k | 19.3% | no data | |||
68,049 | €89.5k | 17.2% | no data |